Nav: Home

Study raises questions about reporting incidental genetic findings

January 05, 2016

A genetic test that suggests a patient may be at increased risk for potentially fatal heart rhythms is very often not as ominous as it sounds.

That's the take-home message from a study in today's Journal of the American Medical Association led by researchers at Vanderbilt University Medical Center.

The study of 2,022 patients identified 63 who had genetic variations considered to be "potentially pathogenic" - capable of producing arrhythmias. Yet their electrocardiograms (ECGs) were no different from those who did not carry the "disease genes."

The results "warn us to be very careful about returning genetic results, particularly to people who have no signs or symptoms of heart disease," said the paper's first author, Sara Van Driest, M.D., Ph.D., assistant professor of Pediatrics and Medicine.

Relying solely on genetic testing without considering the ECG or other data from patients' electronic medical records (EMRs) not only may alarm them unnecessarily, but also can lead to inappropriate and expensive treatments, in this case, implantation of defibrillators that use electrical shocks to restore normal heart rhythm.

"There's this big push to return every (genetic) result back to patients," said senior author Dan Roden, M.D., the William Stokes Professor of Experimental Therapeutics and professor of Medicine and Pharmacology. "This is one way of saying, 'Hold on. Let's make sure we're doing this the right way.'"

Everyone has rare variations in the genetic code that potentially could cause disease, Van Driest added. Many of these variants, however, are actually harmless, as they are found in healthy people. "They're red herrings thrown into the genome," she said.

The study's "silver lining" is that it demonstrates how following a large number of patients through their EMRs over a relatively long period of time can help determine what risk each genetic variation actually carries, she said.
-end-
Researchers from several academic medical centers, health care systems and companies contributed to the study, which was conducted and funded in part through the federally funded Electronic Medical Records and Genomics (eMERGE) network.

Vanderbilt has served as the network's coordinating center since its inception in 2007.

Other Vanderbilt co-authors of the study were Josh Denny, M.D., William Bush, Ph.D., Sarah Stallings, Ph.D., and Quinn Wells, M.D., Pharm.D., M.S.C.I., and M. Benjamin Shoemaker M.D., M.S.C.I. (Master of Science in Clinical Investigation).

Vanderbilt University Medical Center

Related Disease Articles:

Viewpoint: Could disease pathogens be the dark matter behind Alzheimer's disease?
In a lively discussion appearing in the Viewpoint section of the journal Nature Reviews Neurology, Ben Readhead, a researcher in the ASU-Banner Neurodegenerative Disease Research Center at the Biodesign Institute joins several distinguished colleagues to discuss the idea that bacteria, viruses or other infectious pathogens may play a role in Alzheimer's disease.
Tools used to study human disease reveal coral disease risk factors
In a study published in Scientific Reports, a team of international researchers led by University of Hawai'i (UH) at Mānoa postdoctoral fellow Jamie Caldwell used a statistical technique typically employed in human epidemiology to determine the ecological risk factors affecting the prevalence of two coral diseases--growth anomalies, abnormalities like coral tumors, and white syndromes, infectious diseases similar to flesh eating bacteria.
Disease-aggravating mutation found in a mouse model of neonatal mitochondrial disease
The new mitochondrial DNA (mtDNA) variant drastically speeds up the disease progression in a mouse model of GRACILE syndrome.
Human longevity largest study of its kind shows early detection of disease & disease risks
Human Longevity, Inc. (HLI) announced the publication of a ground-breaking study in the journal Proceedings of the National Academy of Sciences (PNAS).
30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.
Long-dormant disease becomes most dominant foliar disease in New York onion crops
Until recently, Stemphylium leaf blight has been considered a minor foliar disease as it has not done much damage in New York since the early 1990s.
Inflammatory bowel disease appears to impact risk of Parkinson's disease
Amsterdam, NL, November 14, 2019 - Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years.
Contact sports associated with Lewy body disease, Parkinson's disease symptoms, dementia
There is mounting evidence that repetitive head impacts from contact sports and other exposures are associated with the neurodegenerative disease chronic traumatic encephalopathy (CTE) and dementia.
In kidney disease patients, illicit drug use linked with disease progression and death
Among individuals with chronic kidney disease, hard illicit drug use was associated with higher risks of kidney disease progression and early death.
Despite reductions in infectious disease mortality in US, diarrheal disease deaths on the rise
Deaths from infectious diseases have declined overall in the United States over the past three decades.
More Disease News and Disease Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.